Vimarsana
Biggest News Aggregation in the World

Page 17 - Wave Life Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Wave Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Wave Life Sciences Today - Breaking & Trending Today

Analysts' Downgrades for July 26th (AGYS, AIZ, BIDU, BIIB, BILI, BIO, CVNA, DY, IOVA, IVZ) - Vimarsana News

Analysts' Downgrades for July 26th (AGYS, AIZ, BIDU, BIIB, BILI, BIO, CVNA, DY, IOVA, IVZ)

Analysts’ downgrades for Wednesday, July 26th: Agilysys (NASDAQ:AGYS) was downgraded by analysts at StockNews.com from a buy rating to a hold rating. Assurant (NYSE:AIZ) was downgraded by analysts at StockNews.com from a buy rating to a hold rating. Baidu (NASDAQ:BIDU) was downgraded by analysts at StockNews.com from a buy rating to a hold rating. Biogen […]

Trevena, Inc. Appoints Mark Corrigan to Board of Directors - Vimarsana News

Trevena, Inc. Appoints Mark Corrigan to Board of Directors

Trevena, Inc. announced that Mark Corrigan, M.D. has been appointed to the Companys Board of Directors, effective July 18 2023. Dr. Corrigan is a highly successful pharmaceutical executive with more...

Wave Life Sciences (NASDAQ:WVE) Research Coverage Started at Raymond James - Vimarsana News

Wave Life Sciences (NASDAQ:WVE) Research Coverage Started at Raymond James

Raymond James started coverage on shares of Wave Life Sciences (NASDAQ:WVE – Free Report) in a research report released on Wednesday, MarketBeat.com reports. The brokerage issued an outperform rating and a $7.00 price target on the stock. Several other equities research analysts have also recently commented on WVE. Jefferies Financial Group cut shares of Wave […]

Wave Life Sciences (NASDAQ:WVE) Now Covered by Raymond James - Vimarsana News

Wave Life Sciences (NASDAQ:WVE) Now Covered by Raymond James

Equities research analysts at Raymond James assumed coverage on shares of Wave Life Sciences (NASDAQ:WVE – Free Report) in a note issued to investors on Wednesday, MarketBeat.com reports. The firm set an “outperform” rating and a $7.00 price target on the stock. Raymond James’ price target indicates a potential upside of 83.73% from the stock’s […]

Wave Life Sciences (NASDAQ:WVE) shareholders have endured a 90% loss from investing in the stock five years ago - Vimarsana News

Wave Life Sciences (NASDAQ:WVE) shareholders have endured a 90% loss from investing in the stock five years ago

We're definitely into long term investing, but some companies are simply bad investments over any time frame. We don't...

Source: yahoo.com